Mechanism of Action of Metformin in PCOS
Metformin works in PCOS primarily by improving insulin sensitivity, which leads to decreased circulating insulin levels, reduced ovarian androgen production, and improved ovulatory function. 1, 2
Primary Mechanisms
Insulin Resistance Improvement
- Metformin directly targets insulin resistance, a central pathophysiological feature in many PCOS patients 1
- Reduces hyperinsulinemia within 4 weeks of treatment initiation 3
- Improves glucose tolerance and maintains it over time 1
Hormonal Effects
- Decreases circulating androgens by:
Reproductive Function Improvement
- Restores menstrual regularity in up to 66.7% of previously amenorrheic women 4
- Improves ovulation rates, particularly in insulin-resistant PCOS patients 3
- Increases estradiol levels, indicating improved follicular development 3
Clinical Effects
Metabolic Benefits
- Reduces HOMA-IR (homeostatic model assessment of insulin resistance) from 4.6 to 2.3 4
- Decreases 2-hour glucose levels (from 117 to 90 mg/dL) 4
- May positively impact cardiovascular risk factors 1
Reproductive Outcomes
- Improves menstrual cyclicity, especially in insulin-resistant women (12 of 15 vs. 3 of 17 in placebo) 3
- Increases ovulation rates (67% of metformin-treated women had at least one ovulation vs. 45% in placebo) 3
- Can enhance fertility when combined with other treatments 2, 5
Important Clinical Considerations
Patient Selection
- Most effective in PCOS patients with:
Limitations
- Not effective as first-line therapy for:
Combination Therapy
- More effective when combined with clomiphene citrate for ovulation induction in clomiphene-resistant patients 5
- Can be used with lifestyle modifications for enhanced metabolic benefits 1, 6
Dosing Considerations
- Typically dosed at 1000-2000 mg daily, often divided into 2-3 doses 5
- May be weight-based (1000 mg for lower weights, 1700 mg for higher weights) 4
- Gradual dose escalation can minimize gastrointestinal side effects
Pitfalls and Caveats
- Metformin is not FDA-approved specifically for PCOS treatment in the US 1
- Response varies significantly based on insulin resistance status - patients without insulin resistance show less improvement in menstrual irregularities 3
- Gastrointestinal side effects are common but often transient
- Should not replace lifestyle modifications as first-line approach for metabolic improvement 6
In conclusion, metformin's primary mechanism in PCOS involves improving insulin sensitivity, which leads to downstream hormonal and reproductive benefits. Its efficacy is most pronounced in insulin-resistant PCOS patients, particularly for improving menstrual regularity and supporting ovulation.